Re: Farmas USA
Creo que se ha dado a conocer la suspension de un trial la semana pasada ... No he podido ver mas
EXEL -5%
CÓDIGO AMIGO
Creo que se ha dado a conocer la suspension de un trial la semana pasada ... No he podido ver mas
EXEL -5%
EXEL
Roche suspends MODUL CRC trial following iDMC review of cohort 4 (Cobimetinib + atezolizumab combo) data
https://clinicaltrials.gov/ct2/show/NCT02291289
Very negative read-through to imminent Ph3 IMblaze370 readout for Cobimetinib + atezolizumab combo in CRC
gracias Ana, joder, todo hostias ultimamente ... :(
Y el +4% del Xbi hoy? Alguno lo ha sentido en las suyas?? Porque de las mias nada ... Y mañana vendra el pullback de marras y ya la volvemos a liar
ACAD
Biotech2k ha decidido vender todas, tanto estas como SAGE.
https://www.investorvillage.com/groups.asp?mb=19595&mn=2107&pt=msg&mid=18178714
I have exited CNS as a whole
I have debated this for a long time. I don't know the science as good as I do for Hematology, Immunology, Oncology and now Genetics. I should have done this when ACAD was at $38 and I first considered it. Then again, I would have missed SAGE going from $55 to $160. This puts a dent into my YTD performance of -4.4% to start the year. After INCY last week and ACAD this week, I think only down -4.4% is a small miracle. Its a testament to spreading out your bets and limiting the downside to maximize the upside.
For ACAD, I lost all my 200% gain and sold today with a long term loss of -12%. That is a tough one to stomach. I am probably selling the bottom here. I know that.
For SAGE, I have a long term gain of over 300%. I think it could be the best CNS company ever. This one had to go too if I was getting out of CNS.
On a trading basis, It actually came out to a net neutral. I had huge massive gains in SAGE that offsets 90% of the short term losses I took in ACAD.
This is going to bring me very heavy into the cash now. I will put it back to work slowly.
XBI velas 1h
ya se ve lo que sera mas probable que nos toque mañana ...
Info confidencial hasta finales de marzo. Sale hoy. A ver si va a ser bueno y es un bear raid. Aquí voy perdida, la verdad.
Edito: parece que nadie sabe en qué afecta esto a exel, pero por lo pronto se confirma que no afecta al ensayo que el mercado està esperando. Por lo pronto me ciño a mi hipótesis de intento de bear raid.